The Analyst Report as published from time to time is included in our website as part of our stakeholders engagement initiatives. The inclusion of such report however does not imply our endorsement of or concurrence with such information, conclusions or recommendations.
Date |
Analyst |
Title |
Apr 03, 2020 |
RHB Research |
Earnings Negativity Priced In; U/G To NEUTRAL |
Feb 26, 2020 |
RHB Research |
Negative On Results, Positive On Divestment |
Feb 26, 2020 |
CIMB Research |
2QFY6/20: Sequentially wider net loss |
Jan 22, 2020 |
RHB Research |
Private Placement On The Cards; Still SELL |
Dec 02, 2019 |
CIMB Research |
1QFY6/20: Low software profit margin |
Sep 03, 2019 |
RHB Research |
No Sign Of Optimism As Yet; Still a SELL |
May 31, 2019 |
RHB Research |
Lacking Catalyst After SKIN; Still a SELL |
Apr 15, 2019 |
RHB Research |
Company claiming RM733m for loss of SKIN |
Mar 01, 2019 |
RHB Research |
All Eyes On The Compensation; Still SELL |
Sep 05, 2018 |
PublicInvest Research |
Secures Master Licensing Agreement 3.0 |
Feb 28, 2018 |
RHB Research |
Another Subdued Quarter |
Feb 28, 2018 |
PublicInvest Research |
Boosted By Construction Profit |
Feb 28, 2018 |
BIMB Securities Research |
Results Review: 4QFY17 |
Feb 28, 2018 |
AM Investment Research |
4Q core profit surges over 4x YoY |
Feb 27, 2018 |
CIMB Research |
4QFY17: Long-term profits from SKIN |
Aug 25, 2017 |
RHB Research |
SKIN May Start In 4Q17 |
Aug 25, 2017 |
BIMB Securities Research |
Strong Quarter Performance |
Aug 25, 2017 |
AM Investment Research |
Earnings Comeback Signals Inflection Point |
Aug 24, 2017 |
CIMB Research |
2Q17: Take Care Of Your SKIN |
Aug 17, 2017 |
AM Investment Research |
Stocks On Radar |
< Previous Page Next Page >